Metamizole: Indications and risks

Metamizole is a powerful analgesic drug whose varying regulatory status from country to country reflects its mixed benefit-risk profile. Patients must be instructed about the risk of agranulocytosis and the symptoms by which it can be recognized early.

Authors

Ralf Baron (ORCID: https://orcid.org/0000-0002-9492-4698)
Ingolf Cascorbi (ORCID: https://orcid.org/0000-0002-2182-9534)

Publication Details

Journal: Deutsches Ärzteblatt international
Published: 2026-01-06
DOI: https://doi.org/10.3238/arztebl.m2025.0214
Primary Topic: Blood disorders and treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Metamizole: Indications and risks

Ralf Baron, Ingolf Cascorbi

Jan 6, 2026

Deutsches Ärzteblatt international

Blood disorders and treatments

article

Metamizole: Indications and risks

Ralf Baron, Ingolf Cascorbi

January 6, 2026article en

Abstract

Deutsches Ärzteblatt international(Forthcoming)

Openalex Percentile: Top 100%

Blood disorders and treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metamizole: Indications and risks — Ralf Baron, Ingolf Cascorbi · Deutsches Ärzteblatt international (2026) | TGRS Research Map | TGRS